Technical Analysis for LOGC - LogicBio Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 9.06 -3.51% -0.33
LOGC closed down 3.51 percent on Wednesday, February 20, 2019, on 22 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Mar 4

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical LOGC trend table...

Date Alert Name Type % Chg
Feb 20 50 DMA Resistance Bearish 0.00%
Feb 20 Weak + Overbought Other 0.00%
Feb 20 Overbought Stochastic Strength 0.00%
Feb 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.51%
Feb 19 Narrow Range Bar Range Contraction -3.51%
Feb 19 NR7 Range Contraction -3.51%
Feb 19 Weak + Overbought Other -3.51%
Feb 19 Inside Day Range Contraction -3.51%
Feb 19 Weak, Overbought and Reversal Signs Reversal -3.51%
Feb 19 Overbought Stochastic Strength -3.51%

Older signals for LOGC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. Its lead product candidate is LB-001 that is been developed for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. LogicBio Therapeutics, Inc. was founded in 2014 and is based in Cambridge, Massachusetts.
Medicine Disease Rare Diseases Medical Genetics Genetic Genealogy
Is LOGC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.0
52 Week Low 6.7
Average Volume 51,871
200-Day Moving Average 0.0
50-Day Moving Average 9.4335
20-Day Moving Average 8.8188
10-Day Moving Average 9.128
Average True Range 0.6677
ADX 9.61
+DI 18.2981
-DI 14.817
Chandelier Exit (Long, 3 ATRs ) 7.5869
Chandelier Exit (Short, 3 ATRs ) 9.8101
Upper Bollinger Band 9.6796
Lower Bollinger Band 7.958
Percent B (%b) 0.64
BandWidth 19.52193
MACD Line -0.0117
MACD Signal Line -0.14
MACD Histogram 0.1283
Fundamentals Value
Market Cap 69.25 Million
Num Shares 7.64 Million
EPS -0.23
Price-to-Earnings (P/E) Ratio -39.56
Price-to-Sales 4.54
Price-to-Book 2.57
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.66
Resistance 3 (R3) 9.73 9.59 9.56
Resistance 2 (R2) 9.59 9.44 9.56 9.53
Resistance 1 (R1) 9.33 9.35 9.26 9.26 9.49
Pivot Point 9.19 9.19 9.16 9.16 9.19
Support 1 (S1) 8.93 9.04 8.86 8.86 8.63
Support 2 (S2) 8.79 8.95 8.76 8.59
Support 3 (S3) 8.53 8.79 8.56
Support 4 (S4) 8.46